Role of CC chemokine signaling in hyperglycemic renal artery stenosis

CC趋化因子信号在高血糖肾动脉狭窄中的作用

基本信息

  • 批准号:
    9215631
  • 负责人:
  • 金额:
    $ 47.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-03-15 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Optimal management of patients with renovascular hypertension (RVH) due to atherosclerotic renal artery stenosis (RAS) is a matter of considerable controversy. Our long-term goal is to identify signaling pathways responsible for the development of ischemic injury in the stenotic kidney and hypertensive injury in the contralateral kidney in the 2-kidney, 1-clip model of RVH. Our recent studies have underscored a critical role for MCP-1 (CCL2) and other members of the CC chemokine family in the development of chronic renal damage in murine RVH. CC chemokine expression plays a critical role in the progression of renal disease in patients with metabolic syndrome and diabetes (MetS-D), but less is known about their role in renovascular disease (RVD). Most studies have focused on chemokine generation by circulating inflammatory cells and tissue macrophages, although parenchymal cells can produce CC chemokines and thereby contribute to injury. The next logical step in our ongoing studies is to elucidate a critical role for CC chemokine signaling by renal parenchymal cells and infiltrating macrophages and other inflammatory cells in the progression of RVD and how this process is modulated by the presence of MetS-D. The central hypothesis underlying our ongoing studies is that CC chemokine signaling directs early events in macrophage influx and polarization, leading to chronic injury, and that chemokine generation by parenchymal cells may contribute to/amplify this process. Furthermore, macrophages play an important role in the development of chronic renal damage in the contralateral kidney, a process that depends on the presence of MetS-D, as suggested by our preliminary studies. Our aims are to 1) test the hypothesis that CC chemokines play a critical role in mediating the development and progression of bilateral chronic renal injury in mice with MetS-D and RVH; 2) test the hypothesis that progression of CKD in mice with MetS-D and RVH requires interaction of CC chemokine signaling through bone marrow derived macrophages and parenchymal cells; and 3) test the hypothesis that M1 polarization is necessary for initiation and progression of renal disease in MetS-D mice with RVH. The proposed studies will provide an essential foundation towards understanding a mechanistic role for macrophage polarization and CC chemokine generation in the development of chronic renal lesions in a novel mouse model of RVH with MetS-D.
描述(由申请人提供):动脉粥样硬化性肾动脉狭窄(RAS)导致的肾血管性高血压(RVH)患者的最佳管理是一个相当有争议的问题。我们的长期目标是在RVH的2肾1夹模型中确定负责狭窄肾中缺血性损伤和对侧肾中高血压损伤发展的信号通路。我们最近的研究强调了MCP-1(CCL 2)和CC趋化因子家族的其他成员在小鼠RVH慢性肾损伤的发展中的关键作用。CC趋化因子表达在代谢综合征和糖尿病(MetS-D)患者的肾脏疾病进展中起着关键作用,但对其在肾血管疾病(RVD)中的作用知之甚少。大多数研究都集中在循环炎性细胞和组织巨噬细胞产生趋化因子,虽然实质细胞可以产生CC趋化因子,从而有助于损伤。我们正在进行的研究的下一个逻辑步骤是阐明CC趋化因子信号传导的关键作用 肾实质细胞和浸润性巨噬细胞和其他炎性细胞在RVD进展中的作用,以及MetS-D的存在如何调节该过程。我们正在进行的研究的核心假设是CC趋化因子信号传导指导巨噬细胞流入和极化的早期事件,导致慢性损伤,并且实质细胞产生的趋化因子可能有助于/放大这一过程。此外,巨噬细胞在对侧肾的慢性肾损伤的发展中起重要作用,这一过程取决于MetS-D的存在,正如我们的初步研究所表明的那样。我们的目的是1)检验CC趋化因子在MetS-D和RVH小鼠中介导双侧慢性肾损伤的发生和进展中起关键作用的假设; 2)检验MetS-D和RVH小鼠中CKD的进展需要CC趋化因子信号通过骨髓源性巨噬细胞和实质细胞的相互作用的假设;以及3)检验M1极化对于患有RVH的MetS-D小鼠中的肾病的开始和进展是必需的这一假设。拟议的研究将提供一个重要的基础,了解机制的作用,巨噬细胞极化和CC趋化因子的产生在慢性肾脏病变的发展,在一个新的小鼠模型的RVH与MetS-D。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Correlation of Glomerular Size With Donor-Recipient Factors and With Response to Injury.
  • DOI:
    10.1097/tp.0000000000003570
  • 发表时间:
    2021-11-01
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Grande JP;Helgeson ES;Matas AJ
  • 通讯作者:
    Matas AJ
Management of renal artery stenosis: What does the experimental evidence tell us?
肾动脉狭窄的治疗:实验证据告诉我们什么?
  • DOI:
    10.4330/wjc.v6.i8.855
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    1.9
  • 作者:
    Al-Suraih,Mohammed;Grande,JosephPeter
  • 通讯作者:
    Grande,JosephPeter
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH PETER GRANDE其他文献

JOSEPH PETER GRANDE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH PETER GRANDE', 18)}}的其他基金

Role of CC chemokine signaling in hyperglycemic renal artery stenosis
CC趋化因子信号在高血糖肾动脉狭窄中的作用
  • 批准号:
    9012745
  • 财政年份:
    2013
  • 资助金额:
    $ 47.39万
  • 项目类别:
Role of CC chemokine signaling in hyperglycemic renal artery stenosis
CC趋化因子信号在高血糖肾动脉狭窄中的作用
  • 批准号:
    8502985
  • 财政年份:
    2013
  • 资助金额:
    $ 47.39万
  • 项目类别:
Role of CC chemokine signaling in hyperglycemic renal artery stenosis
CC趋化因子信号在高血糖肾动脉狭窄中的作用
  • 批准号:
    8634016
  • 财政年份:
    2013
  • 资助金额:
    $ 47.39万
  • 项目类别:
Signaling Pathways in Renovascular Hypertension
肾血管性高血压的信号通路
  • 批准号:
    7327508
  • 财政年份:
    2007
  • 资助金额:
    $ 47.39万
  • 项目类别:
Analytical & Histopathology Core
分析型
  • 批准号:
    7327516
  • 财政年份:
    2007
  • 资助金额:
    $ 47.39万
  • 项目类别:
Signaling Pathways in Pathogenesis of Renal Fibrosis
肾纤维化发病机制中的信号通路
  • 批准号:
    6331264
  • 财政年份:
    2001
  • 资助金额:
    $ 47.39万
  • 项目类别:
Signaling Pathways in Pathogenesis of Renal Fibrosis
肾纤维化发病机制中的信号通路
  • 批准号:
    6788757
  • 财政年份:
    2001
  • 资助金额:
    $ 47.39万
  • 项目类别:
Signaling Pathways in Pathogenesis of Renal Fibrosis
肾纤维化发病机制中的信号通路
  • 批准号:
    6617844
  • 财政年份:
    2001
  • 资助金额:
    $ 47.39万
  • 项目类别:
Signaling Pathways in Pathogenesis of Renal Fibrosis
肾纤维化发病机制中的信号通路
  • 批准号:
    6524238
  • 财政年份:
    2001
  • 资助金额:
    $ 47.39万
  • 项目类别:
OMEGA 3 FATTY ACIDS IN IGA NEPHROPATHY
IGA 肾病中的 OMEGA 3 脂肪酸
  • 批准号:
    2150039
  • 财政年份:
    1994
  • 资助金额:
    $ 47.39万
  • 项目类别:

相似国自然基金

High-precision force-reflected bilateral teleoperation of multi-DOF hydraulic robotic manipulators
  • 批准号:
    52111530069
  • 批准年份:
    2021
  • 资助金额:
    10 万元
  • 项目类别:
    国际(地区)合作与交流项目

相似海外基金

A Study of Policy Convergence between Multilateral and Bilateral Donors' Support for Community Participation in Education in Cambodia
柬埔寨社区参与教育的多边和双边捐助者支持政策趋同研究
  • 批准号:
    24K05750
  • 财政年份:
    2024
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Bilateral ESRC/FNR: Training Executives to Enhance Employee Engagement in Government: Field Experimental Evidence from Luxembourg
双边 ESRC/FNR:培训高管以提高员工在政府中的参与度:来自卢森堡的现场实验证据
  • 批准号:
    ES/W010380/1
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Research Grant
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
  • 批准号:
    10702126
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
Optimizing bilateral and single-sided-deafness cochlear implants for functioning in complex auditory environments
优化双侧和单侧耳聋人工耳蜗植入物以在复杂的听觉环境中发挥作用
  • 批准号:
    10654316
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
Investigating subthreshold vestibular stimulation as a strategy for rehabilitation in individuals with bilateral vestibular hypofunction
研究阈下前庭刺激作为双侧前庭功能减退患者的康复策略
  • 批准号:
    10571440
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
Conference: NSF/UKRI Bilateral Workshop on Quantum Information Science in Chemistry
会议:NSF/UKRI 化学中量子信息科学双边研讨会
  • 批准号:
    2403812
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Standard Grant
Factors for bilateral capital inflows into emerging market economies from advanced economies
发达经济体双边资本流入新兴市场经济体的因素
  • 批准号:
    23K01461
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Shift from Unilateral to Bilateral Sensory-Motor Connectivity in Chronic Hemiparetic Stroke
慢性偏瘫中风从单侧感觉运动连接转向双侧感觉运动连接
  • 批准号:
    10991213
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
Bilateral wheat improvement workshop with BalticWheat network
与波罗的海小麦网络双边小麦改良研讨会
  • 批准号:
    BB/T018291/1
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Research Grant
Bilateral ESRC/FNR: Banking on Europe
双边 ESRC/FNR:欧洲银行业
  • 批准号:
    ES/W000733/2
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了